Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study
- PMID: 19264142
- PMCID: PMC2805435
- DOI: 10.1016/j.neuroimage.2009.02.029
Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study
Abstract
MDMA (3,4-methylenedioxymethamphetamine; Ecstasy) is a popular recreational drug that produces long-lasting serotonin (5-HT) neurotoxicity consisting of reductions in markers for 5-HT axons. 5-HT innervates cortical and subcortical brain regions mediating motor function, predicting that MDMA users will have altered motor system neurophysiology. We used functional magnetic resonance imaging (fMRI) to assay motor task performance-associated brain activation changes in MDMA and non-MDMA users. 24 subjects (14 MDMA users and 10 controls) performed an event-related motor tapping task (1, 2 or 4 taps) during fMRI at 3 T. Motor regions of interest were used to measure percent signal change (PSC) and percent activated voxels (PAV) in bilateral motor cortex, sensory cortex, supplementary motor area (SMA), caudate, putamen, pallidum and thalamus. We used SPM5 to measure brain activation via three methods: T-maps, PSC and PAV. There was no statistically significant difference in reaction time between the two groups. For the Tap 4 condition, MDMA users had more activation than controls in the right SMA for T-score (p=0.02), PSC (p=0.04) and PAV (p=0.03). Lifetime episodes of MDMA use were positively correlated with PSC for the Tap 4 condition on the right for putamen and pallidum; with PAV in the right motor and sensory cortex and bilateral thalamus. In conclusion, we found a group difference in the right SMA and positive dose-response association between lifetime exposure to MDMA and signal magnitude and extent in several brain regions. This evidence is consistent with MDMA-induced alterations in basal ganglia-thalamocortical circuit neurophysiology and is potentially secondary to neurotoxic effects on 5-HT signaling. Further studies examining behavioral correlates and the specific neurophysiological basis of the observed findings are warranted.
Figures





Similar articles
-
MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.Drug Alcohol Depend. 2012 Jan 1;120(1-3):41-7. doi: 10.1016/j.drugalcdep.2011.06.022. Epub 2011 Jul 31. Drug Alcohol Depend. 2012. PMID: 21807471 Free PMC article.
-
Potential long-term effects of MDMA on the basal ganglia-thalamocortical circuit: a proton MR spectroscopy and diffusion-tensor imaging study.Radiology. 2011 Aug;260(2):531-40. doi: 10.1148/radiol.11101918. Epub 2011 Jun 1. Radiology. 2011. PMID: 21633053
-
Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.Psychopharmacology (Berl). 2013 May;227(1):41-54. doi: 10.1007/s00213-012-2936-1. Epub 2012 Dec 16. Psychopharmacology (Berl). 2013. PMID: 23241648 Free PMC article.
-
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.Neuropsychobiology. 2000;42(1):11-6. doi: 10.1159/000026665. Neuropsychobiology. 2000. PMID: 10867551 Review.
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
Cited by
-
MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.Drug Alcohol Depend. 2012 Jan 1;120(1-3):41-7. doi: 10.1016/j.drugalcdep.2011.06.022. Epub 2011 Jul 31. Drug Alcohol Depend. 2012. PMID: 21807471 Free PMC article.
-
Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioning.J Int Neuropsychol Soc. 2010 Nov;16(6):1047-55. doi: 10.1017/S1355617710000846. Epub 2010 Aug 25. J Int Neuropsychol Soc. 2010. PMID: 20735886 Free PMC article.
-
Using Functional Magnetic Resonance Imaging to Describe Pain Pathways in the 'Oldest Old': A Case Study of a Healthy 97-year-old Female.J Pain Relief. 2012 Oct 15;1(5):111. doi: 10.4172/2167-0846.1000111. Epub 2012 Aug 27. J Pain Relief. 2012. PMID: 32206444 Free PMC article. No abstract available.
-
Oscillatory serotonin function in depression.Synapse. 2013 Nov;67(11):801-20. doi: 10.1002/syn.21675. Epub 2013 May 21. Synapse. 2013. PMID: 23592367 Free PMC article. Review.
-
Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research.Brain Behav. 2012 Jul;2(4):499-523. doi: 10.1002/brb3.65. Epub 2012 Jun 26. Brain Behav. 2012. PMID: 22950052 Free PMC article.
References
-
- Alexander GE, Crutcher MD, DeLong MR. Basal ganglia–thalamocortical circuits: parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res. 1990;85:119–146. - PubMed
-
- Balogh B, Molnar E, Jakus R, Quate L, Olverman HJ, Kelly PA, Kantor S, Bagdy G. Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology (Berl) 2004;173:296–309. - PubMed
-
- Bankson MG, Cunningham KA. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin–dopamine interactions. J Pharmacol Exp Ther. 2001;297:846–852. - PubMed
-
- Brett M, Anton JL, Valabregue R, Poline JB. Region of interest analysis using an SPM toolbox 2002
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous